Anebulo Pharmaceuticals Ownership 2024 | Who Owns Anebulo Pharmaceuticals Now?
Institutional Ownership
28.18%
Insider Ownership
65.38%
Retail Ownership
6.44%
Institutional Holders
12.00
Anebulo Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
22NW, LP | 20.69% | 12.50% | 5,366,290 | - | - | 14,649,972 | Jun 30, 2024 |
LVW ADVISORS, LLC | 2.48% | 0.26% | 642,039 | - | - | 1,752,767 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 1.97% | 0.08% | 511,073 | - | - | 1,395,229 | Jun 30, 2024 |
MORGAN STANLEY | 1.54% | 0.00% | 399,219 | - | - | 1,089,868 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.61% | 0.08% | 157,862 | - | - | 430,964 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.59% | - | 153,873 | 401 | 0.26% | 420,073 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.20% | - | 51,308 | 28,531 | 125.26% | 140,129 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.00% | 18,978 | - | - | 51,810 | Jun 30, 2024 |
BLACKROCK INC. | 0.01% | - | 3,761 | -288 | -7.11% | 10,267 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,300 | -1,838 | -35.77% | 9,009 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 65 | 65 | 100.00% | 177 | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | 10 | 1 | 11.11% | 27 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -62 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
Anebulo Pharmaceuticals's largest institutional shareholder is 22NW, LP, holding 20.69% of the company's total share outstanding, currently valued at $14.65M. The top 10 institutional shareholders own together 28.18% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
22NW, LP | 20.69% | 12.50% | 5,366,290 | - | - | 14,649,972 | Jun 30, 2024 |
LVW ADVISORS, LLC | 2.48% | 0.26% | 642,039 | - | - | 1,752,767 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 1.97% | 0.08% | 511,073 | - | - | 1,395,229 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.61% | 0.08% | 157,862 | - | - | 430,964 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.00% | 18,978 | - | - | 51,810 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,300 | -1,838 | -35.77% | 9,009 | Jun 30, 2024 |
MORGAN STANLEY | 1.54% | 0.00% | 399,219 | - | - | 1,089,868 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.20% | - | 51,308 | 28,531 | 125.26% | 140,129 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.59% | - | 153,873 | 401 | 0.26% | 420,073 | Jun 30, 2024 |
BLACKROCK INC. | 0.01% | - | 3,761 | -288 | -7.11% | 10,267 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 65 | 65 | 100.00% | 177 | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | 10 | 1 | 11.11% | 27 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -62 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
The largest Anebulo Pharmaceuticals shareholder by % of total assets is 22NW, LP. The company owns 5.37M shares of Anebulo Pharmaceuticals (ANEB), representing 12.50% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 0.20% | - | 51,308 | 28,531 | 125.26% | 140,129 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.59% | - | 153,873 | 401 | 0.26% | 420,073 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 65 | 65 | 100.00% | 177 | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | 10 | 1 | 11.11% | 27 | Jun 30, 2024 |
MORGAN STANLEY | 1.54% | 0.00% | 399,219 | - | - | 1,089,868 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.00% | 18,978 | - | - | 51,810 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.61% | 0.08% | 157,862 | - | - | 430,964 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 1.97% | 0.08% | 511,073 | - | - | 1,395,229 | Jun 30, 2024 |
LVW ADVISORS, LLC | 2.48% | 0.26% | 642,039 | - | - | 1,752,767 | Jun 30, 2024 |
22NW, LP | 20.69% | 12.50% | 5,366,290 | - | - | 14,649,972 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -62 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
BLACKROCK INC. | 0.01% | - | 3,761 | -288 | -7.11% | 10,267 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,300 | -1,838 | -35.77% | 9,009 | Jun 30, 2024 |
As of Jun 30 2024, Anebulo Pharmaceuticals's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 28.53K stocks of ANEB, valued at $140.13K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 3,300 | -1,838 | -35.77% | 9,009 | Jun 30, 2024 |
BLACKROCK INC. | 0.01% | - | 3,761 | -288 | -7.11% | 10,267 | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -62 | -100.00% | - | Jun 30, 2024 |
22NW, LP | 20.69% | 12.50% | 5,366,290 | - | - | 14,649,972 | Jun 30, 2024 |
LVW ADVISORS, LLC | 2.48% | 0.26% | 642,039 | - | - | 1,752,767 | Jun 30, 2024 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 1.97% | 0.08% | 511,073 | - | - | 1,395,229 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.61% | 0.08% | 157,862 | - | - | 430,964 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.00% | 18,978 | - | - | 51,810 | Jun 30, 2024 |
MORGAN STANLEY | 1.54% | 0.00% | 399,219 | - | - | 1,089,868 | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | 10 | 1 | 11.11% | 27 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 65 | 65 | 100.00% | 177 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.59% | - | 153,873 | 401 | 0.26% | 420,073 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.20% | - | 51,308 | 28,531 | 125.26% | 140,129 | Jun 30, 2024 |
As of Jun 30 2024, Anebulo Pharmaceuticals's biggest institutional seller is TOWER RESEARCH CAPITAL LLC (TRC). The company sold -1.84K shares of ANEB, valued at $9.01K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -62 | -100.00% | - | Jun 30, 2024 |
Anebulo Pharmaceuticals's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -0.14K shares, valued at -, as of undefined.
Anebulo Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 153,472 | 87,643 | 133.14% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 7,407 | 1,420 | 23.72% | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 264 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 366 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 636 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 3,683 | -96 | -2.54% | Mar 31, 2024 |
Anebulo Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 153.47K shares, compromising 0.00% of its total assets.
Anebulo Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 12 | -14.29% |
31 Mar, 24 | 14 | 7.69% |
31 Dec, 23 | 13 | 18.18% |
30 Sep, 23 | 11 | - |
30 Jun, 23 | 11 | 22.22% |
31 Mar, 23 | 9 | -25.00% |
31 Dec, 22 | 12 | 20.00% |
30 Sep, 22 | 10 | 25.00% |
30 Jun, 22 | 8 | - |
31 Mar, 22 | 8 | - |
31 Dec, 21 | 8 | 14.29% |
30 Sep, 21 | 7 | -12.50% |
30 Jun, 21 | 8 | - |
As of 30 Jun 24, 12 institutions are holding Anebulo Pharmaceuticals's shares, representing a decrease of -14.29% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 7,307,778 | 0.02% |
31 Mar, 24 | 7,306,365 | 0.38% |
31 Dec, 23 | 7,278,993 | 3.24% |
30 Sep, 23 | 7,050,491 | 0.26% |
30 Jun, 23 | 7,031,883 | 2.86% |
31 Mar, 23 | 6,836,130 | -2.98% |
31 Dec, 22 | 7,046,307 | 2.97% |
30 Sep, 22 | 6,842,912 | 46.28% |
30 Jun, 22 | 4,677,847 | 11.63% |
31 Mar, 22 | 4,190,412 | -0.07% |
31 Dec, 21 | 4,193,307 | 0.24% |
30 Sep, 21 | 4,183,214 | -0.40% |
30 Jun, 21 | 4,199,876 | - |
Anebulo Pharmaceuticals (ANEB) has 7.31M shares outstanding as of 30 Jun 24, up 0.02% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 28.18% | 3.51% |
31 Mar, 24 | 28.33% | 3.56% |
31 Dec, 23 | 28.22% | 3.57% |
30 Sep, 23 | 28.12% | 3.74% |
30 Jun, 23 | 27.43% | 3.86% |
31 Mar, 23 | 26.67% | 3.53% |
31 Dec, 22 | 27.49% | 3.22% |
30 Sep, 22 | 29.22% | 7.28% |
30 Jun, 22 | 20.04% | 6.22% |
31 Mar, 22 | 17.95% | 5.56% |
31 Dec, 21 | 17.96% | 5.59% |
30 Sep, 21 | 17.92% | 3.40% |
30 Jun, 21 | 22.96% | - |
As of 30 Jun 24, Anebulo Pharmaceuticals is held by 28.18% institutional shareholders, representing a 3.51% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 4 | -33.33% |
31 Mar, 24 | 6 | -14.29% |
31 Dec, 23 | 7 | 40.00% |
30 Sep, 23 | 5 | 25.00% |
30 Jun, 23 | 4 | 33.33% |
31 Mar, 23 | 3 | -25.00% |
31 Dec, 22 | 4 | - |
30 Sep, 22 | 4 | 33.33% |
30 Jun, 22 | 3 | - |
31 Mar, 22 | 3 | - |
31 Dec, 21 | 3 | 200.00% |
30 Sep, 21 | 1 | -87.50% |
30 Jun, 21 | 8 | - |
4 institutional shareholders have increased their position in ANEB stock as of 30 Jun 24 compared to 6 in the previous quarter (a -33.33% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 2 | -33.33% |
31 Mar, 24 | 3 | - |
31 Dec, 23 | 3 | 50.00% |
30 Sep, 23 | 2 | - |
30 Jun, 23 | 2 | 100.00% |
31 Mar, 23 | 1 | -66.67% |
31 Dec, 22 | 3 | -40.00% |
30 Sep, 22 | 5 | 400.00% |
30 Jun, 22 | 1 | -66.67% |
31 Mar, 22 | 3 | 50.00% |
31 Dec, 21 | 2 | -50.00% |
30 Sep, 21 | 4 | - |
30 Jun, 21 | - | - |
2 institutional shareholders have reduced their position in ANEB stock as of 30 Jun 24 compared to 3 in the previous quarter (a -33.33% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 12 | -14.29% | 7,307,778 | 0.02% | 28.18% | 3.51% | 4 | -33.33% | 2 | -33.33% |
31 Mar, 24 | 14 | 7.69% | 7,306,365 | 0.38% | 28.33% | 3.56% | 6 | -14.29% | 3 | - |
31 Dec, 23 | 13 | 18.18% | 7,278,993 | 3.24% | 28.22% | 3.57% | 7 | 40.00% | 3 | 50.00% |
30 Sep, 23 | 11 | - | 7,050,491 | 0.26% | 28.12% | 3.74% | 5 | 25.00% | 2 | - |
30 Jun, 23 | 11 | 22.22% | 7,031,883 | 2.86% | 27.43% | 3.86% | 4 | 33.33% | 2 | 100.00% |
31 Mar, 23 | 9 | -25.00% | 6,836,130 | -2.98% | 26.67% | 3.53% | 3 | -25.00% | 1 | -66.67% |
31 Dec, 22 | 12 | 20.00% | 7,046,307 | 2.97% | 27.49% | 3.22% | 4 | - | 3 | -40.00% |
30 Sep, 22 | 10 | 25.00% | 6,842,912 | 46.28% | 29.22% | 7.28% | 4 | 33.33% | 5 | 400.00% |
30 Jun, 22 | 8 | - | 4,677,847 | 11.63% | 20.04% | 6.22% | 3 | - | 1 | -66.67% |
31 Mar, 22 | 8 | - | 4,190,412 | -0.07% | 17.95% | 5.56% | 3 | - | 3 | 50.00% |
31 Dec, 21 | 8 | 14.29% | 4,193,307 | 0.24% | 17.96% | 5.59% | 3 | 200.00% | 2 | -50.00% |
30 Sep, 21 | 7 | -12.50% | 4,183,214 | -0.40% | 17.92% | 3.40% | 1 | -87.50% | 4 | - |
30 Jun, 21 | 8 | - | 4,199,876 | - | 22.96% | - | 8 | - | - | - |
Anebulo Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Anebulo Pharmaceuticals's stock was made by English Aron R. on Dec 20 2023, selling 300,000 shares at - per share (valued at -).
Anebulo Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 1 | - | - |
Q4 2023 | 4 | 1 | 400.00% |
Q3 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | 3 | - | - |
Q2 2022 | 8 | - | - |
Q1 2022 | 1 | - | - |
Q4 2021 | 4 | - | - |
Q2 2021 | 2 | 8 | 25.00% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Anebulo Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q3 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 4 | - | - |
Q2 2021 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Anebulo Pharmaceuticals's stocks.
ANEB Ownership FAQ
Who Owns Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals is owned by institutional shareholders (28.18%), insiders (65.38%), and public (6.44%). The largest institutional shareholder of Anebulo Pharmaceuticals is 22NW, LP (20.69% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals's major institutional shareholders are 22NW, LP, LVW ADVISORS, LLC, NANTAHALA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and IKARIAN CAPITAL, LLC. The top five shareholders own together 27.29% of the company's share outstanding.
How many Anebulo Pharmaceuticals shareholders are there?
As of Jun 2024, there are 12 institutional shareholders of Anebulo Pharmaceuticals.
What percentage of Anebulo Pharmaceuticals is owned by 22NW, LP?
22NW, LP owns 5.37M shares of Anebulo Pharmaceuticals, representing 20.69% of the company's total shares outstanding, valued at $14.65M (as of Jun 2024).
What percentage of Anebulo Pharmaceuticals is owned by LVW ADVISORS, LLC?
As of Jun 2024, LVW ADVISORS, LLC holds 642.04K shares of Anebulo Pharmaceuticals (ANEB), compromising 2.48% of the company, valued at $1.75M.
What percentage of Anebulo Pharmaceuticals is owned by NANTAHALA CAPITAL MANAGEMENT, LLC?
NANTAHALA CAPITAL MANAGEMENT, LLC is the third largest holder of Anebulo Pharmaceuticals. The company owns 511.07K of the company's shares outstanding (worth $1.4M).